AKAMIS BIO
Company Overview
Social Media Profiles
About Akamis Bio
Description
Akamis Bio is an innovative clinical-stage oncology company focused on transforming cancer treatment through its advanced tumor gene therapy platform. Committed to enhancing the lives of cancer patients, the company develops cutting-edge solutions that harness the power of biotechnology within the life sciences industry.
Specialties
Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics
Innovative tumor gene therapy platform
Solid tumor targeting via intravenous delivery
Enhancing antitumor immune responses
Combination therapies with immuno-oncology agents
Products & Services
Tumor-Specific Immuno-Gene Therapies
Solid Tumor Treatments
Combination Immuno-Oncology Agents
Gene Therapy Platforms
Biotechnology Solutions for Oncology
Contact Information
Email Addresses
Competitors & Similar Companies(6)
Moderna, Inc.
BioNTech SE
CureVac N.V.
Vertex Pharmaceuticals
Sangamo Therapeutics, Inc.
Amgen Inc.
News & Media
Search Terms:
akamis bio
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Frequently Asked Questions about Akamis Bio
Where is Akamis Bio located?
The headquarter of Akamis Bio is located in Oxfordshire, England, United Kingdom
What is the email address of Akamis Bio?
The email addresses of Akamis Bio are [email protected]
What is the official website of Akamis Bio?
The official website of Akamis Bio is https://www.akamisbio.com
What industry does Akamis Bio belong to?
Akamis Bio belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Akamis Bio?
Akamis Bio specializes in Tumor-Specific Immuno-Gene (T-SIGn®) therapeutics, Innovative tumor gene therapy platform, Solid tumor targeting via intravenous delivery, Enhancing antitumor immune responses, Combination therapies with immuno-oncology agents.
What products and services is Akamis Bio likely to offer?
Akamis Bio offers Tumor-Specific Immuno-Gene Therapies, Solid Tumor Treatments, Combination Immuno-Oncology Agents, Gene Therapy Platforms, Biotechnology Solutions for Oncology.
Who are the competitors of Akamis Bio?
Competitors of Akamis Bio are Moderna, Inc., BioNTech SE, CureVac N.V., Vertex Pharmaceuticals, Sangamo Therapeutics, Inc., Amgen Inc..
What does Akamis Bio do?
Akamis Bio is an innovative clinical-stage oncology company focused on transforming cancer treatment through its advanced tumor gene therapy platform. Committed to enhancing the lives of cancer patients, the company develops cutting-edge solutions that harness the power of biotechnology within the life sciences industry.